Palonosetron plus 1-day dexamethasone for the prevention of nausea and vomiting due to moderately emetogenic chemotherapy: effect of established risk factors on treatment outcome in a phase III trial
published in: The Journal of Supportive Oncology
date of publication: 2011-09-23
main subject: dexamethasone, phase III clinical trial, (3aS)-palonosetron
Cites articles
There is nothing here
Article - wd:Q82061044